Skip to content

Tectonic Therapeutics TECX Increase (Decrease) in Prepaid Expense and Other Assets

Increase (Decrease) in Prepaid Expense and Other Assets at other companies

ALN
Alnylam PharmaceuticalsALNY
$6.32M-80.7%
Septerna, Inc. logo
Septerna, Inc.SEPN
$294K-39.8%
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
$912K-83.5%
Opko Health logo
Opko HealthOPK
-$6.97M-155%
Ginkgo Bioworks logo
Ginkgo BioworksDNA
-$5.93M-1,121%
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$3.79M-71.2%

Other financials

Income statement

See full
Operating income-$27.3M-49.2%
Net income-$25.2M-58.7%
EPS (diluted)-$1.34-44.1%

Balance sheet

See full
Cash & equivalents$236.9M-22.8%
Total debt$4.9M+86.1%
Total equity$230.4M-23.5%
Total assets$246.6M-21.7%

Cash flow

See full
Operating cash flow-$18.4M-40.7%
CapEx$19.0K-29.6%
Free cash flow-$18.4M-40.6%

Valuation

See full
Market cap$585.51M+58.3%
Enterprise value$353.51M+438%

Returns & leverage

See full
Return on equity-31.4%
Debt / equity0.0×
Current ratio18.5×-4.4×

Where this comes from

Reported directly by Tectonic Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: Tectonic Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tectonic Therapeutics's increase (decrease) in prepaid expense and other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tectonic Therapeutics's increase (decrease) in prepaid expense and other assets?
Tectonic Therapeutics (TECX) reported increase (decrease) in prepaid expense and other assets of $46K in Q1 2026.
How has Tectonic Therapeutics's increase (decrease) in prepaid expense and other assets changed year-over-year?
Tectonic Therapeutics's increase (decrease) in prepaid expense and other assets increased by 102.1% year-over-year, from -$2.22M to $46K.
What is the long-term trend for Tectonic Therapeutics's increase (decrease) in prepaid expense and other assets?
Over 2 years (2022 to 2024), Tectonic Therapeutics's increase (decrease) in prepaid expense and other assets has grown at a 13.8% compound annual growth rate (CAGR), from -$2.47M to $3.19M.
What does increase (decrease) in prepaid expense and other assets mean?
This tracks changes in cash paid in advance for goods or services that will be consumed in future periods. It reflects the timing difference between cash outflows and the recognition of related expenses on the income statement.